pharma · Covid-19 · Chronic Myocardial Ischemia · LSTA
Lisata Therapeutics
LISATA THERAPEUTICS, INC.
Lisata Therapeutics clinical programs — 9 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 110 Allen Road, 2nd Flr, Basking Ridge, NJ 07920, US
- Founded
- 2006
- Employees
- 38
- Programs
- 15
- Drugs
- 13
- Patents
- 1
Lisata Therapeutics projects
9 ClinicalTrials.gov programs sponsored by Lisata Therapeutics.
Lisata Therapeutics has 9 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
CLBS03 Low Dose
LISATA THERAPEUTICS, INC.
Diabetes Mellitus
1 trial -
CLBS12
LISATA THERAPEUTICS, INC.
Critical Limb Ischemia
1 trial -
CLBS14 (low-dose)
LISATA THERAPEUTICS, INC.
Myocardial Ischemia
1 trial -
CLBS16
LISATA THERAPEUTICS, INC.
Coronary Microvascular Dysfunction
2 trials -
NBS10
LISATA THERAPEUTICS, INC.
ST Segment Elevation Myocardial Infarction
1 trial -
certepetide
LISATA THERAPEUTICS, INC.
Cholangiocarcinoma
1 trial -
certepetide
LISATA THERAPEUTICS, INC.
Pancreas Cancer
1 trial -
lymphokine-activated killer cells
LISATA THERAPEUTICS, INC.
Brain and Central Nervous System Tumors
1 trial -
therapeutic autologous dendritic cells
LISATA THERAPEUTICS, INC.
Melanoma (Skin)
1 trial
Frequently asked questions
How many clinical projects does Lisata Therapeutics have?
9 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.